Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chiara Nicci"'
Publikováno v:
Oncology Reviews, Vol 6, Iss 1 (2012)
Hematopoiesis, the process by which the hematopoietic stem cells and progenitors differentiate into blood cells of various lineages, involves complex interactions of transcription factors that modulate the expression of downstream genes and mediate p
Externí odkaz:
https://doaj.org/article/76322914300f45aa92cce8987f9a9913
Autor:
Paola Tacchetti, Patrizia Tosi, Michele Cavo, Annamaria Brioli, Delia Cangini, Giuliana Leopardi, Elena Zamagni, Alessandro Gozzetti, Antonio Ledda, Francesco Casulli, Nicoletta Testoni, Massimo Offidani, Carolina Terragna, Affra Carubelli, Alessandro Petrucci, Lucia Pantani, Claudia Cellini, Michele Baccarani, Silvestro Volpe, Giulia Perrone, Chiara Nicci, Luciano Masini, Francesco Di Raimondo, Michela Ceccolini, Catello Califano, Francesca Patriarca, Lucio Catalano, Mauro Fiacchini
Publikováno v:
ResearcherID
Abstract 349 We report here on the final analysis of the multicenter phase II “Bologna 2002” study which incorporated thal-dex into double ASCT with high-dose melphalan (200 mg/m2) as front-line therapy for younger patients with symptomatic multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa59c7796c3e930643ae76ba1f60e3d
http://hdl.handle.net/20.500.11769/75921
http://hdl.handle.net/20.500.11769/75921
Autor:
Michela Palmisano, Tiziana Grafone, Michele Baccarani, Sergio Storti, Giovanni Martinelli, Chiara Nicci, Ottaviani Emanuela, Alberto M. Martelli
Publikováno v:
Hematological oncology. 26(3)
FLT3 mutation and overexpression in most acute myeloid leukaemia (AML) patients make this tyrosine kinase receptor an attractive therapeutic target. FLT3 kinase inhibitors are actually in clinical trials, thus it is critical to develop a reproducible
Autor:
Patrizia Tosi, Carolina Terragna, Giovanni Martinelli, Chiara Nicci, Claudia Cellini, Luciano Guardigni, Michele Baccarani, Delia Cangini, Tiziana Grafone, Michela Ceccolini, Nicoletta Testoni, Matteo Renzulli, Michele Cavo, Elena Zamagni, Giulia Perrone, Paola Tacchetti
Publikováno v:
Scopus-Elsevier
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
Autor:
Simona Luatti, Maria Rosa Motta, Nicoletta Testoni, Tiziana Grafone, Giulia Marzocchi, Giovanni Martinelli, Michele Baccarani, Chiara Nicci, Michele Malagola, Michela Tonelli, Emanuela Ottaviani
Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac6cf0358a7f217f11aea17054035da8
http://hdl.handle.net/11585/2708
http://hdl.handle.net/11585/2708
Autor:
Pier Francesco Ferrucci, Giulio Giordano, Chiara Nicci, Rosa Tambaro, Giuliana Farina, Tiziana Grafone, Bruno Zappacosta, Sergio Storti, Silvia Piano, Stefano Papini
Publikováno v:
Oncology Reports.
In neoplastic patients chemotherapy frequently involves severe myeloid suppression. Sometimes myeloid suppression is the main cause of therapy recycling delay with severe and prolonged neutropenia, anaemia and thrombocytopenia. Our study aimed to ver
Autor:
Piero Maria Stefani, Affra Carubelli, Michela Ceccolini, Sadia Falcioni, Claudia Cellini, Alessandro Gozzetti, Lucio Catalano, Patrizia Tosi, Francesca Patriarca, MC Pallotti, Matteo Renzulli, Michele Baccarani, Nicoletta Testoni, Giulia Perrone, Francesco Casulli, Carolina Terragna, Antonio Ledda, Francesco Di Raimondo, Lucia Pantani, Luciano Masini, Paola Tacchetti, Elena Zamagni, Mauro Fiacchini, Silvestro Volpe, Catello Califano, Chiara Nicci, Michele Cavo, Annamaria Brioli
Publikováno v:
ResearcherID
The phase II “Bologna 2002” clinical study incorporated thalidomide-dexamethasone (thal-dex) into double ASCT with melphalan (200 mg/m2) as frontline therapy for patients with symptomatic multiple myeloma (MM) and less than 65 years of age. By st
Autor:
Paola Tacchetti, Carolina Terragna, Patrizia Tosi, Elena Zamagni, Michele Cavo, Annamaria Brioli, Chiara Nicci, Elena Montanari, Michele Baccarani, Tiziana Grafone, Delia Cangini, Giovanni Martinelli, Nicoletta Testoni, Giulia Perrone, Michela Ceccolini, Matteo Renzulli
Publikováno v:
ResearcherID
Aim of the present sudy was to evaluate the benefit of novel agents combined with conventional therapies in multiple myeloma (MM), with particular emphasis on patients (pts) carrying adverse cytogenetic abnormalities. For this purpose, we analyzed a
Autor:
Chiara Nicci, Simona Soverini, Matteo Renzulli, Tiziana Grafone, Delia Cangini, Michele Baccarani, Giulia Perrone, Nicoletta Testoni, Claudia Cellini, Michele Cavo, Paola Tacchetti, Elena Zamagni, Giovanni Martinelli, Patrizia Tosi, Carolina Terragna
Publikováno v:
Blood. 106:5072-5072
The chromosome (chr.) 4p16 is involved in one of the alteration most frequently described in Multiple Myeloma (MM) patients at diagnosis, t(4;14). This translocation (tr.) affects the IgH locus on chr.14q32, and a conserved gene cluster region, on ch
Autor:
Simona Luatti, Gianantonio Rosti, Simonetta Kerim, Chiara Nicci, Giancarlo Discepoli, Giorgina Specchia, Elisabetta Abruzzese, Michele Baccarani, Nicoletta Testoni, Marco Mancini, Paolo Bernasconi, Ursula Giussani, Antonio Cuneo, Alfonso Zaccaria, Giulia Marzocchi, Cristina Mecucci, Elena Montanari, Giovanna Rege-Cambrin, Giovanni Martinelli
Publikováno v:
Blood. 106:4857-4857
To asses cytogenetic pattern of early diagnosed chronic phase chronic myeloid leukemia (CML) patients and to evaluate the role of either conventional (CC) and molecular cytogenetics in three multicentric studies, karyotype and interphase fluorescence